Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to Plasmodium falciparum in Mozambican Children

Table 3 Ratios between prototype Th1:Th2 and pro-: anti-inflammatory cytokines.

		5 months		9 months		12 months		24 months
		Ratio	95% CI	Ratio	95% CI	Ratio	95% CI	Ratio	95% CI
	Overall	32	31.73 - 32.27	39	38.73 - 39.27	25	24.69 - 25.31	71	70.75 - 71.25
IFN-γ:IL-4	SP	26	25.64 - 26.36	32	31.62 - 32.38	21	20.61 - 21.39	56	55.62 - 56.38
	Placebo	40	39.62 - 40.38	49	48.62 - 49.38	31	30.54 - 31.46	91	90.68 - 91.32
	Overall	14	13.80 - 14.20	8	7.79 - 8.21	8	7.78 - 8.22	4	3.69 - 4.31
TNF:IL-10	SP	13	12.71 - 13.29	8	7.73 - 8.27	8	7.70 - 8.30	4	3.58 - 4.42
	Placebo	14	13.73 - 14.27	8	7.69 - 8.31	8	7.67 - 8.33	5	4.55 - 5.45

ISSN: 1471-2172